Lam Research Corporation $LRCX Shares Sold by Fulcrum Asset Management LLP

Key Points

• Fulcrum Asset Management cut its Lam Research position by 43.5% in the second quarter, selling 6,570 shares and retaining 8,534 shares valued at approximately $3.5 million. Institutional investors and hedge funds collectively own 84.61% of LRCX.
• Lam Research reported quarterly EPS of $1.82, ahead of the $1.69 consensus, while revenue rose 30% year over year to $6.72 billion. Management issued fiscal Q1 2027 EPS guidance of $2.00 to $2.30.
• The company increased its quarterly dividend by 27% to $0.33 per share, while analysts maintain a “Moderate Buy” consensus rating and an average price target of $357.31; however, China-related trade restrictions and tariffs remain key risks.

Fulcrum Asset Management LLP lowered its position in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 43.5% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 8,534 shares of the semiconductor company's stock after selling 6,570 shares during the quarter. Fulcrum Asset Management LLP's holdings in Lam Research were worth $3,507,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in LRCX. Norges Bank acquired a new position in shares of Lam Research during the fourth quarter worth about $3,645,427,000. Price T Rowe Associates Inc. MD increased its stake in Lam Research by 352.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company's stock valued at $2,344,347,000 after purchasing an additional 10,666,540 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in Lam Research in the second quarter valued at $3,777,585,000. Franklin Resources Inc. increased its position in shares of Lam Research by 57.0% in the fourth quarter. Franklin Resources Inc. now owns 10,110,560 shares of the semiconductor company's stock valued at $1,730,724,000 after buying an additional 3,671,073 shares in the last quarter. Finally, Corient Private Wealth LLC raised its stake in shares of Lam Research by 235.5% during the 4th quarter. Corient Private Wealth LLC now owns 5,199,441 shares of the semiconductor company's stock worth $890,040,000 after buying an additional 3,649,553 shares during the last quarter. Institutional investors and hedge funds own 84.61% of the company's stock.

Lam Research Price Performance

LRCX stock opened at $301.90 on Friday. The stock has a market capitalization of $377.77 billion, a price-to-earnings ratio of 52.41, a price-to-earnings-growth ratio of 1.26 and a beta of 1.84. The company has a quick ratio of 1.91, a current ratio of 2.63 and a debt-to-equity ratio of 0.30. Lam Research Corporation has a 52-week low of $94.11 and a 52-week high of $438.50. The stock's fifty day simple moving average is $330.43 and its 200-day simple moving average is $289.14.

Lam Research (NASDAQ:LRCX - Get Free Report) last released its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The firm had revenue of $6.72 billion during the quarter, compared to analyst estimates of $6.66 billion. During the same period in the prior year, the firm posted $1.33 earnings per share. The business's quarterly revenue was up 30.0% compared to the same quarter last year. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Equities research analysts expect that Lam Research Corporation will post 9.32 EPS for the current year.

Lam Research Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 14th. Investors of record on Wednesday, September 23rd will be given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 0.4%. This is a positive change from Lam Research's previous quarterly dividend of $0.26. The ex-dividend date of this dividend is Wednesday, September 23rd. Lam Research's dividend payout ratio (DPR) is currently 18.06%.

More Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam Research broke ground on a 120,000-square-foot Oregon semiconductor laboratory as part of a planned investment of more than $3 billion in its global lab network over five years. The project is intended to accelerate process innovations for advanced AI chips and improve collaboration with customers, supporting the company’s long-term growth prospects. Lam Research breaks ground on AI semiconductor lab in Oregon
• Positive Sentiment: The board approved a 27% increase in the quarterly dividend, from $0.26 to $0.33 per share. The payout is scheduled for October 14, 2026, for shareholders of record on September 23, providing a modest shareholder-return signal. Lam Research Corporation Announces a 27% Increase in Quarterly Dividend
• Neutral Sentiment: Lam’s latest earnings exceeded consensus expectations, with quarterly earnings per share of $1.82 versus the $1.69 estimate and revenue of $6.72 billion. Revenue increased 30% year over year, while management issued fiscal first-quarter 2027 EPS guidance of $2.00 to $2.30. Analysts’ median price target remains substantially above recent trading levels, although Mizuho recently lowered its target to $365.
• Neutral Sentiment: Two long-serving directors, Michael R. Cannon and Sohail U. Ahmed, plan to retire from the board on November 2, 2026. The transition could refresh governance but introduces some near-term uncertainty regarding board composition. Lam Research Announces Retirement of Michael R. Cannon and Sohail U. Ahmed from Board of Directors
• Negative Sentiment: Investors appear increasingly concerned about tariffs, export restrictions and other U.S.-China trade measures. China was Lam’s largest geographic market in fiscal 2026, making the company particularly sensitive to policy changes that could reduce demand, hurt margins or disrupt its supply chain. These macro concerns have overshadowed the dividend increase and Oregon expansion. Lam Research Slides as China Trade Risk Appears to Outweigh Dividend Hike
• Negative Sentiment: Reported insider activity shows selling rather than buying by executives and directors over the past six months, which may reinforce caution among investors, though such transactions can reflect personal financial planning rather than a view on company fundamentals.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on LRCX shares. Weiss Ratings raised shares of Lam Research from a "buy (b-)" rating to a "buy (b)" rating in a research note on Friday, August 21st. UBS Group reiterated a "buy" rating and set a $375.00 target price (up from $310.00) on shares of Lam Research in a report on Tuesday, June 9th. Jefferies Financial Group set a $335.00 price objective on Lam Research and gave the company a "buy" rating in a research report on Thursday, July 30th. Susquehanna reaffirmed a "positive" rating and set a $475.00 price objective (up from $385.00) on shares of Lam Research in a research note on Tuesday, June 30th. Finally, Bank of America boosted their target price on shares of Lam Research from $330.00 to $480.00 and gave the company a "buy" rating in a research note on Tuesday, June 23rd. One research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $357.31.

Insider Buying and Selling

In other news, Director Eric Brandt sold 54,500 shares of the company's stock in a transaction on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the completion of the sale, the director directly owned 199,205 shares in the company, valued at $69,881,114. This represents a 21.48% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Y. Talwalkar sold 18,282 shares of the company's stock in a transaction dated Monday, July 13th. The stock was sold at an average price of $335.00, for a total value of $6,124,470.00. Following the sale, the director owned 87,142 shares of the company's stock, valued at $29,192,570. This represents a 17.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 80,441 shares of company stock valued at $27,614,296. Insiders own 0.31% of the company's stock.

About Lam Research

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source